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Determining cell mechanical properties is increasingly recognized as a
marker-free way to characterize and separate biological cells. This emerging
realization has led to the development of a plethora of appropriate mea-
surement techniques. Here, we use a fairly novel approach, deterministic
lateral displacement (DLD), to separate blood cells based on their mechan-
ical phenotype with high throughput. Human red blood cells were treated
chemically to alter their membrane deformability and the effect of this altera-
tion on the hydrodynamic behaviour of the cells in a DLD device was
investigated. Cells of defined stiffness (glutaraldehyde cross-linked erythro-
cytes) were used to test the performance of the DLD device across a range of
cell stiffness and applied shear rates. Optical stretching was used as an inde-
pendent method for quantifying the variation in stiffness of the cells. Lateral
displacement of cells flowing within the device, and their subsequent exit
position from the device were shown to correlate with cell stiffness. Data
showing how the isolation of leucocytes from whole blood varies with
applied shear rate are also presented. The ability to sort leucocyte sub-
populations (T-lymphocytes and neutrophils), based on a combination of
cell size and deformability, demonstrates the potential for using DLD
devices to perform continuous fractionation and/or enrichment of leucocyte
sub-populations from whole blood.
1. Introduction
Cell deformability is an important emerging bio-marker for a number of disease
states [1]. Deformability is indicative of underlying membrane, cytoskeletal or
nuclear changes associated with a wide range of cell functional changes, such
as differentiation or mitosis [2–4], or disease processes (e.g. cancer) [5–8].
For example, a reduction in erythrocyte (RBC) deformability is a contributing
factor seen in many human disease pathologies and has recently been a topic
of growing research interest. Diseases such as diabetes, sickle cell anaemia
and malaria, as well as hereditary blood disorders such as spherocytosis, ellip-
tocytosis and ovalocytosis all exhibit characteristic losses in RBC deformability
with onset and progression of the pathological state. For the case of Plasmodium
falciparum malaria, recent experiments have shown that the membrane stiffness
of the parasitized RBC can increase more than 50-fold during intra-erythrocytic
parasite maturation [9]; with malaria-infected erythrocytes showing progressive
stiffening with parasite growth [10]. A reduction in stiffness has recently been
& 2014 The Authors. Published by the Royal Society under the terms of the Creative Commons Attribution
License http://creativecommons.org/licenses/by/4.0/, which permits unrestricted use, provided the original
author and source are credited.identified as a potential marker in populations of pluripotent
stem cells, while expression levels of the transcription factor
NANOG, implicated in regulating pluripotency, have been
shown to impact embryonic stem cell stiffness [11]. Leucocytes
show changes in stiffness in response to activation with anti-
gens or other stimuli [12,13], and metastatic cancer cells often
show a ‘softer’ phenotype than healthy cells of the same
origin [6].
An attractive benefit of cell stiffness as a bio-marker is
minimal requirements for sample preparation or labelling
(e.g. with magnetically or fluorescently labelled antibodies),
which reduces sample preparation time and cost. It also
leaves the cells in an unperturbed state, which can be impor-
tant when the cells are to be used for transplantation after
mechanical characterization and sorting.
The power of the mechanical phenotyping approach rests
on the fact that the stiffness is largely determined by the cytos-
keleton of cells, which in turn is involved in many important
cell processes, such as cell polarization, migration, division,
mechano-sensingorphagocytosis.Anyphysiologicalorpatho-
logical change in these functions necessarily leads to a change
inthecytoskeletonandthusincellstiffness,whichcanbemon-
itored by appropriate techniques. This intimate link between
cell stiffness and cell function and its implications for biotech-
nological and biomedical applications, as well as the inherent
interest in cell biological questions, has led to the development
of many different cell mechanics measurement technologies.
The most prominent methods are nano-indentation with
atomic force microscopy [14], micropipette aspiration [15],
magnetic twisting cytometry [16], microplate deformation
[17] and optical stretching [18]. All of these have particular
strengths and weaknesses, but are generally marked by rela-
tively low throughput (less than 100 cells h
21), which has
hindered further biological and biotechnological application.
A recent development in the field of cell mechanics is the
use of microfluidic approaches to facilitate sample handl-
ing and allow high-throughput probing of cell mechanical
properties. A particular variant, deformability cytometry,
allows the measurement of up to thousands of cells per
second, but only for a few seconds [7,19]. Analysis occurs
post-measurement making instantaneous sorting during the
measurement impossible. The most promising microfluidic
techniques rely on inertial focusing and other hydrodynamic
forces generated in microfluidic channels with carefully
designed geometries; these devices do allow for continuous
high-throughput single-cell sorting [20].
Deterministic lateral displacement (DLD) is another
powerful microfluidic technique capable of high-resolution
continuous sorting of cells and other microscopic particles
[21–24]. DLD devices consist of arrays of pillars positioned
within a flow channel. Objects smaller than a critical size
move in the direction of flow (i.e. along the channel axis) and
objects larger than the critical size move in a direction defined
by the pillar arrangement (i.e. they are laterally displaced). For
rigid spherical objects, the operation of the device is straight-
forward [25]. However, biological objects (e.g. cells) are often
compliant and non-spherical and their deformability and
shape are known to influence the trajectories in DLD devices.
Our group and others [26] have recently developed microflui-
dic DLD devices capable of sorting cells according to both size
and deformability.
Figure 1 shows the typical pillar arrangement found in a
DLD device. An array of micrometre-sized pillars is set at an
angletothedirectionoffluidflowthroughamicrofluidicchan-
nel. Figure 1a showsa simulationof the flow velocitiesthrough
an infinite array of such pillars. As described previously [25],
the total fluid flux through the gap between the pillars can be
divided into a number of flow streams (drawn as black lines
in the figure), each of which carries equal fluid flux. Particles
flowing in the DLD device will follow different trajectories
through the device depending on their size. To a first approxi-
mation particles above and below a critical size Dc will follow
different paths through the array of pillars. The critical diam-
eter being a function of the pillar diameter; the inter-pillar
gap, g; the array period, l; and the row shift fraction, 1 as
describedinfigure1b.Theintercolumndistanceforthedevices
usedinthisworkisalsol,givingapillarlatticeslopeof1tothe
average direction of flow.
The dynamics of rigid spherical particles flowing in DLD
arrays are well understood, and the critical particle size is
reasonably well described by the following equation:
Dc ¼ 2hg1,( 1 :1)
where g is the gap between the pillars and h a parameter
which accounts for non-uniform parabolic flow through the
gap. It is possible to continuously separate a range of particle
maximum
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Figure 1. Schematic showing the fluid streamlines (at low Reynolds number) through an array of pillars. Each column is shifted vertically by 1l relative to the
previous column, where l is the inter-pillar distance, 1 is the column shift fraction and g the gap between the pillars. The flow between the pillars is assumed to
be parabolic with streamlines being divided by stall lines which begin and terminate on the pillars. The horizontal flow velocity is indicated by the colour intensity.
(Online version in colour.)
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2sizes by placing arrays of different critical particle sizes
in series.
The behaviour of non-spherical particles, such as erythro-
cytes, is less well understood and they demonstrate complex
dynamic behaviour as they flow through the pillar array.
Shear forces acting on non-spherical particles will tend to
align these particles with their long axis along the direction
of flow and presenting their short axis as the apparent size in
the DLD device (e.g. the displacement properties of biconcave
erythrocytes in the DLD devices will appearasthat of a sphere
of diameter approx. 2.7 mm). Shear-related particle orientation
is a well-understood phenomenon and has been previously
described for non-spherical particles flowing in DLD devices
[26]. With increased flow velocity comes higher shear forces
and particle deformation becomes an issue of increased impor-
tance, further complicating the dynamic behaviour of particles
in these systems. Particles therefore present an ‘apparent size’
to the DLD device, which is a result of both shear-related
orientation and deformation.
In this work, we present characterization of deformabil-
ity-based cell separation in a DLD device. Cells of defined
stiffness (glutaraldehyde cross-linked erythrocytes) are
used to test the performance of the device. Optical stretching
and digital holography are used to independently measure
differences in the viscoelastic properties of these cells,
thus allowing better understanding of the DLD system for
deformability-based cell separation. We also demonstrate
the effect of shear rate on the lateral displacement of leuco-
cyte sub-populations within similar devices and show our
work towards continuous fractionation of whole blood
leucocyte populations.
2. Material and methods
2.1. Cell samples and buffers
Blood samples were obtained via fingerprick: 50 ml of whole
blood was collected and the cells washed three times in 2 ml of
isotonic phosphate buffered saline (PBS) solution (0.01 M phos-
phate, 0.137 M NaCl, 0.0027 M KCl) containing 2 mM EDTA.
2.2. Treatment of erythrocytes with glutaraldehyde
Blood cells were resuspended at haematocrit of 2.5% by volume in
the required concentrations of glutaraldehyde (0–0.01% in PBS)
and incubated at room temperature for 45 min. The samples
wereagainwashedthreetimesinPBSandresuspendedinrunning
buffer (PBS with 0.1% w/v Pluronic F108, Sigma, UK). A final cell
density of 1   10
5cells ml
21 was used in all experiments.
2.3. Fluorescent labelling of leucocytes
Fiftymicrolitresof whole bloodwas dilutedinto 1 mlof PBS(1:20
v/v) containing 2 mM EDTA. One microlitre of 1 mM CellTracker
dye (CMFDA, Molecular Probes) was then added to the sample.
The sample was incubated for 10 min at room temperature
and then run through the device, without further washing of
the sample.
2.4. Fluorescent labelling of leucocyte sub-populations
Fifty microlitres of whole blood was incubated with fluorescently
conjugated monoclonal antibodies directed against CD3 (Alexa647)
and CD16 (Alexa488) (both from BioLegend, San Diego, CA, USA)
for15 mininthedarkat 48C,tofluorescentlylabelthe T-lymphocyte
and neutrophil populations, respectively. The entire blood sample
was then diluted into 1 ml of PBS (1: 20 v/v) containing 2 mM
EDTA and run through the device.
2.5. Microfluidic device fabrication
Two microfluidic device geometries were used throughout this
work: (i) a shallow, 4.5 mm channel height, geometry was used
for the experiments involving erythrocytes as this device con-
fined the erythrocytes (reduced the number of degrees of
freedom) ensuring they flow through the device presenting
their major axis perpendicular to the direction of flow within
the DLD device and (ii) a deeper, 25 mm channel height, geome-
try that allowed the erythrocytes to align with the flow (present
their minor axis perpendicular to the direction of flow) and pass
through the DLD device without lateral displacement. The
microfluidic devices comprised polydimethylsiloxane (PDMS)
channel structures bonded to glass microscope slides. Channel
designs were produced in AUTOCAD. Standard photolithography
techniques were used to produce a silicon (Si) master from which
PDMS channel structures were cast. The process is summarized
in the following: a chrome mask (JD Photo Tools, UK) was
used to pattern a 1.8 mm thick layer of positive tone photoresist
(Microposit S1818, Shipley, UK) spun onto a 100 mm Si wafer
(Compart Technology Ltd, Tamworth, UK). The exposed photo-
resist was developed using Microposit MF319 (Shipley, UK) and
hard-baked on a hotplate at 1158C for 5 min. The wafer was then
dry etched using an STS-DRIE system running the Bosch process,
with the patterned photoresist acting as a protective etch mask.
Following etching, the photoresist was removed in acetone leav-
ing the patterned wafer. The Si wafer was passivated by
immersing for 10 min in a 1% solution of tridecafluoro(1,1,2,2-
tetrahydrooctyl)trichlorosilane in toluene; this step allowed
subsequent release of cured PDMS from the Si master. A 10: 1
mixture of degassed PDMS was poured onto the wafer and
baked overnight at 658C until fully cured. Individual PDMS
devices were then cut from the cured PDMS block and inlet
and outlet holes punched using a biopsy punch (Technical Inno-
vations, USA). The PDMS structures and the glass slides were
both rinsed in isopropyl alcohol and blown dry prior to
plasma treatment using a BD-20 Laboratory Corona Treater
(Electro-Technic Products Inc., Chicago, IL, USA). Glass and
PDMS were then brought into contact within a few seconds of
treatment and left in an oven overnight at 658C to fully bond.
2.6. Experimental set-up
The microfluidic chips were mounted on a fluorescence micro-
scope (Nikon Eclipse) to allow imaging of cells passing through
the device. One of two cameras was used depending on the
requirement of the experimental observation: either an Orca-ER
(Hamamatsu) or a high-speed image intensified camera (Focu-
scope SV-200, Photron). Image processing was carried out using
IMAGEJ and bespoke image analysis code written in MATHEMATICA.
Buffers and cell samples were introduced into the device under
thecontrolofamulti-channelflowcontroller(MFCS-8C,Fluigent),
which allowed accurate control of the applied pressure between 0
and 1300 mbar. Sample reservoirs were connected to the chip
using small bore Tygon tubing (1/1600 outer diameter   0.51 mm
inner diameter)andshort sectionsof23Gstainless steeltube (Elve-
flow, Paris, France). The camera and pump were both controlled
via PC and in-house written LABVIEW code.
2.7. Sample introduction and channel priming
The microfluidic device was first primed with a 0.5% (w/v) sol-
ution of Pluronic F-108 surfactant in PBS. The wetting properties
of the Pluronic solution allowed for easy filling of the microfluidic
channels andpurging of air bubbles. Following channel filling, the
Pluronicwasallowedtoincubateforaminimumof20 mininorder
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3to block the PDMS and glass surfaces from further hydrophobic
and other non-specific adhesive interactions with the red cell. The
system was then flushed with 1 ml of PBS containing 1% (w/v)
bovine serum albumin. Cell samples were then introduced to the
channel sample inlet and running buffer was introduced via
the adjacent buffer inlet channels. Outlet channels were held at
atmospheric pressure.
2.8. Optical stretcher
Optical trapping and stretching of erythrocytes was performed
using a bespoke optical stretcher. The optical stretcher is an estab-
lished technique for measuring the mechanical properties of cells
in suspension using optical fields. The system used was similar
to previously described systems [27,28] and will therefore only
be briefly described here. The optical stretcher consists of a dual-
beam fibre-optical trap aligned perpendicularly to a microfluidic
flow channel (square cross-section glass capillary). The optical
fibres and flow channel were aligned and held in place using a
micro alignment structure fabricated photolithographically from
SU8onaglasssubstrate.Whenrunningcellscanbestablytrapped,
in the optical stretcher, from a flowing fluid at a low optical power
(ca 100 mW) and held in position. If a higher power is used, the
optical forces at the surface of the cell, which are concentrated on
the beam axis, become large enough to measurably deform the
cell. The forces exerted on the cell depend on the laser power,
the arrangement of the trap and the refractive index of the cell
and suspending medium. For most cell types, the optical forces
being exerted [29,30] canbe calculated, which cangive the compli-
ance from the measured uniaxial deformation. In our set-up, the
light power in both beams was held at 100 mWallowing trapping
of individual cells. When transiently increased to 600 mW, the
increased radiation pressure causes the cell to deform (‘stretch’).
3. Results and discussion
Figure 2a shows a schematic of the DLD separation devices
usedthroughoutthiswork.Thedevicecomprisesmultiplesec-
tions, each with a characteristic critical diameter. Each section
of the device is designed to laterally displace particles with a
size greater than Dc by 200 mm. The first section of the device
has Dc ¼ 3 mm and each section has a progressively larger
valueofDc increasingby 0.5 mm with each subsequent section.
Figure2b,cshowstheetchedsiliconmasterforcastingofPDMS
devicesandacutsectionthroughaPDMS deviceclearlyshow-
ing the vertical pillar profiles.
increasing angle
critical size increases for each stage in device
calibration beads:
fluid flow
1.6mm
Dc=4mm
2.6mm
Dc=5mm
3.2mm
Dc=5.5mm
8.8 µm
Dc=9 µm
10 µm
15mm
12mm
8.3 µm
4.3 µm
4.3, 8.3, 10mm at 2×106 particlesml–1
buffer
(a)
(d)
(b)
(c)
buffer small
particles
intermediate
particles
large
particles
sample
Figure 2. (a) Schematic of DLD separation device showing multiple sections each designed to achieve a characteristic critical diameter. (b) DRIE etched silicon master
for casting of PDMS devices. (c) Section through a PDMS device showing the pillars. Depending on the cell type under study, the height of the pillars was varied:
approximately 4 mm tall pillars for erythrocyte work and approximately 25 mm for experiments involving whole blood. (d) Micrographs showing the trajectories of
a mixture of rigid polymer beads (i.e. non-deformable particles) at different positions along the DLD device. The numbers by each image correspond to the vertical
column to column shift, and the associated critical diameter for that particular section of the DLD device. (Online version in colour.)
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43.1. Deterministic lateral displacement of hard spherical
objects
In order to assess the performance of the DLD device, a mixed
sample of polymer beads was run through the device. Typical
particle velocities are less than 1 mm s
21, and as such inertial
effects are negligible with the Reynolds number of the order of
10
22.F i g u r e2 d shows the trajectories of rigid polymer beads
(i.e. non-deformable particles) at different positions along the
DLD device. A mix of 4.3, 8.3 and 10 mm latex beads was intro-
duced to the device and imaged at various positions along the
device. Clear separation of the different size beads is observed
at the outlet and other positions along the length of the device.
3.2. Increased glutaraldehyde concentration confers
increased stiffness to erythrocytes
Human erythrocytes were treated with varying concentra-
tions of glutaraldehyde to modify the stiffness of the cells.
The glutaraldehyde acts through cross-linking of the cellular
proteins specifically those of the spectrin network and associ-
ated proteins [31]. A highly fixed cell is essentially a discoid-
shaped non-deformable rigid body (i.e. an extreme in terms
of membrane rigidity). Cells exposed to fixation under less
severe conditions (i.e. lower concentrations of glutaraldehyde)
showeddifferingdegreesoffixationanddifferentlevelsofstiff-
ness. Glutaraldehyde concentrations in the cross-linking
solution were varied from 0% up to 0.1%. Samples of cells
weretreatedsimilarlyand measuredusingtheopticalstretcher
andon the DLD cell fractionationdevice. No observable differ-
ences were seen in the morphology of the glutaraldehyde-
treated and untreated erythrocytes; this is supported by our
observations and in agreement with previous work using
similar treatment conditions [31].
3.3. Optical stretching correlates with erythrocyte
stiffness
Figure3ashowsaschematicoftheopticalstretcherset-upanda
cell undergoing stretching. Treatment of cells with different
concentrations of glutaraldehyde resulted in well-defined
increases in cell stiffness. Figure 3b s h o w si m a g e sf r o mt h ec e l l
stretching experiments for a range of different concentrations
of glutaraldehyde. The optical stretcher data showed a mono-
tonic increase in cell stiffness with increasing glutaraldehyde
concentration up to concentrations of approximately 0.02%.
Figure 3c shows stretch data up to 0.003% glutaraldehyde con-
centration. Above this concentration, the erythrocytes no
longer deform under the applied forces achievable using the
opticalstretcher. Thisprogressiveincrease incellstiffness corre-
lates well with data from other groups, where very large
increases in stiffness were seen with glutaraldehyde concen-
trations in the range between 0 and 0.025% [31]. Quantitative
phase measurements, using digital holographic microscopy
(seetheelectronicsupplementarymaterial)showedanegligible
increase in refractive index of cells treated with glutaraldehyde;
even extremely high levels (0.1%). Glutaraldehyde treatment
introduced less than 1% bias into the stretch measurement
across the concentration range used in this work. Changes in
theopticalpropertiesofthecellsfollowingtreatmentwithglutar-
aldehyde can therefore have only negligible influence on the
magnitude of the cell stretching observed. The degree of cell
stretchingistherefore taken to be a goodmeasure of thestiffness
ofthemeasurederythrocytes.Astheshapeandrefractiveindices
of the erythrocytes remained the same for the different con-
ditions (i.e. across the range of glutaraldehyde concentrations),
the compliance of the cells can be assumed to be directly
proportional to the measured optically induced deformations.
3.4. Separation of erythrocytes of different stiffness
using deterministic lateral displacement
To assess the effect of stiffness on the hydrodynamic trajec-
tories of the cells flowing though the DLD device, samples
of untreated and glutaraldehyde-treated erythrocytes were
run through the DLD device under a range of flow conditions
(i.e. varying levels of shear stress). Video images of the cells
within the device and their distribution across the width of
outlet of the device were recorded. Samples of defined stiff-
ness (i.e. defined concentration of glutaraldehyde) were run
optical
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Figure 3. (a) Schematic of the optical stretching set-up. (b) Microscope images of trapped erythrocytes held under 100 mW power (left) and stretched erythrocytes
under 600 mW power (right). Each row of images shows cells having been exposed to different glutaraldehyde concentrations (concentration is noted in the right
upper corner of each panel). (c) Average stretching curves for erythrocytes with various levels of glutaraldehyde cross-linking (n . 20 for each concentration). Solid
lines represent power law fits to the data. Error bars show standard error of mean. (Online version in colour.)
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5through the device as well as mixture of cells having differing
stiffness (i.e. mixtures of cells which were exposed to different
glutaraldehyde concentrations and subsequently washed and
mixed together in known concentrations). Figure 4a shows a
microscope image of the outlet of the DLD device. The data
in the image and histogram are from an experiment where
a mixture of 0 and 0.01% glutaraldehyde-fixed erythrocytes
was run through the device with an applied pressure of
1000 mbar. The histogram shows the cell distribution at the
outlet of the DLD device (it should be noted that the displa-
cement direction across the channel is reversed with respect
to that of figures 1 and 2). The high-magnification images
(top right, figure 4a) show high-speed video images of the
deformation of compliant (0% glutaraldehyde) and stiff
(0.01% glutaraldehyde) erythrocytes as they interact with
the pillars within the DLD device. Figure 4b shows the displa-
cement of untreated erythrocytes under a range of different
flow conditions. Progressive images show the position of
the erythrocytes for increasing levels of shear rate (shear
rate increasing as images progress from left to right). The
data in figure 4c show the average lateral displacement at
the outlet of the DLD device, for three erythrocyte popu-
lations of clearly defined stiffness across a range of applied
shear rates.
3.5. Separation of leucocytes using deterministic lateral
displacement
The effect of shear rate on the separation of human leucocytes
was also investigated, again using washed whole blood. Simi-
lar devices to those described above, for the erythrocyte work,
were used to study the separation of leucocytes from 1:20
diluted whole blood. For this work, the DLD device channel
depth was approximately 25 mm. This channel geometry
allows the RBCs more degrees of rotational freedom and
these cells tend to align with their minor axis presenting
acrossthe inter-pillargap. For this pillar gapsize and flow con-
dition used, the RBCs experience no lateral displacement
within these taller devices. The leucocyte population does,
however, experience a lateral displacement in these devices,
which is seen to vary with shear rate. This variation in the
lateral displacement with shear rate is a result of the cells dis-
torting in the fluid; this has been well documented in DLD
devices [19] and other microfluidic flow regimes [23] and
could clearly be seen in the DLD devices used in this work
(data not shown). As a result, as the leucocytes flow through
the device their apparent size decreases with increasing
shear. Figure 5a shows a fluorescence image of the outlet of
theDLDdevice, theleucocytes have been labelledwith afluor-
escentCellTrackerdyetoallowvisualizationandcanbeseenas
bright objects towards the right-hand side of the image. The
erythrocytes all flow to the leftmost outlet of the device. The
histograms in figure 5b show the characteristic distribution of
theleucocytepopulationattheoutletofthedeviceasafunction
of applied pressure at the channel inlet (with the outlet held at
atmospheric pressure). The leucocyte displacement follows a
similar relaxation in the magnitude of lateral displacement as
that of the RBCs (as seen in the shallow device geometry,
described above). This reduction in the lateral displacement
with increased shear rate is again attributed to the distortion
of the cell shape due to shear stress on the cells as they pass
through the device and interact with the pillars.
With increased shear rate, the leucocyte distributions, as a
whole, clearly show less lateral displacement. However, due
to the heterogeneous mixture of cell types making up the leu-
cocyte population in whole blood, one might expect that the
changing cell distributions contain regions (i.e. certain lateral
displacements) that show enrichment or depletion of certain
sub-populations of the leucocyte population. It should be
noted that any change in the apparent size of the cells due to
shear as they flow through the device will be a combination
of both cell size (the average size of the leucocyte cell
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Figure 4. (a) Photograph of the outlet of the shallow DLD device showing separation of RBCs of different stiffness (mixture of 0 and 0.01% glutaraldehyde-fixed
erythrocytes). Histogram shows cell distribution at the outlet for a mix of untreated and glutaraldehyde-treated RBCs (note that the displacement direction is
reversed with respect to figures 1 and 2). The high-magnification images (top right) show deformation of compliant (0% glutaraldehyde) and stiff (0.01% glutar-
aldehyde) erythrocytes as they interact with the pillars within the DLD device. (b) Photographs of the outlet of the DLD device showing displacement of untreated
erythrocytes at different flow rates (increasing flow rates are shown from left to right). (c) Variation in lateral displacement versus flow rate for erythrocytes of
different stiffness. (Online version in colour.)
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6whole blood diluted 1:20 in PBS RBCs
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Figure 5. (a) Microscope image showing separation of leucocytes (bright labelled cells) from whole blood using the deep DLD device. Leucocytes are labelled with
CellTracker dye. Erythrocytes are not displaced (the greater depth of the device means they are free to orient along the direction of fluid flow) and run straight
through to the outlet at the top left. (b) Lateral displacement of leucocytes (WBCs) is shown as a function of flow rate. Lateral displacement is seen to decrease as
the flow rate is increased; this is due to cells deforming under shear. (Online version in colour.)
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Figure 6. (a) Images of fluorescently labelled leucocyte sub-populations (in diluted whole blood) flowing through the outlet of the deep DLD device. T-lymphocytes
and neutrophils clearly exit the device with different displacement distributions. The bright vertical lines in the image are created from superimposition of multiple
video frames; each image shows several hundred cells superimposed. (b) Histogram showing the lateral distribution of the T-lymphocyte and neutrophil populations
at the outlet of the device.
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7populationsdiffersamongthecelltypes)andthedeformability
of the cell. To this end, we performed experiments using 1:20
PBS diluted whole blood that had the T-lymphocyte and
neutrophil populations fluorescently labelled with different
fluorophorestoallowsimultaneousimagingofthedistribution
of these sub-populations of cells at the outlet of the DLD
device. Figure 6a shows multiple superimposed video images
of the labelled cells flowing through the outlet of the device.
At low shear rates (applied pressure 20 mbar), all the leuco-
cytes within the sample were seen to be displaced laterally
across the majority of the width of the device and exited in a
band close to the rightmost channel wall of the device. At
higher shear rates (ca 200 mbar), the leucocytes are seen to
undergo deformation as they flow through the device. As
described above, this deformation results in an apparent
reduction of the cell size within the device, resulting in a
reduction in the lateral displacement seen at the outlet of the
device. Under certain conditions of flow (i.e. appropriately
chosen shear rates), it can be demonstrated that sub-
populations of the leucocytes exit the device with differing
degrees of lateral displacement, thus showing the potential
for the development of a continuous leucocyte fractionation
device. The histogram shown in figure 6b shows the distri-
butions of T-lymphocytes (labelled with CD3-Alexa647) and
neutrophils (labelled with CD16-Alexa488) at the outlet of
the DLD device. Two clear distributions can be seen in the
histograms. The populations show some overlap, but care-
ful design of the outlet ports of the device should allow
continuous fractionation of leucocyte sub-populations under
appropriate flow conditions.
4. Conclusion
We have demonstrated the effect of cell stiffness on separation
in a DLD device and have shown stiffness to be a useful par-
ameter for separation in such devices. Erythrocytes treated
within a range of concentrations of glutaraldehyde (0–0.01%)
show a near linear increase in cell stiffness with concentration.
Through the use of optical stretching,we measured the relative
stiffness of different cell populations and we are able to show
for the first time a direct correlation between cell stiffness and
lateral displacement in a DLD device.
The stiffness of the chemically modified RBCs used in this
work is similar to that of erythrocytes infected with the
malaria parasite P. falciparum (previously measured via opti-
cal stretching [32]), thus demonstrating the potential of using
the DLD technique as a method for isolating malaria-infected
cells from blood. We are currently continuing this work and
further developing the DLD technique, in collaboration with
colleagues at the London School of Hygiene and Tropical
Medicine with the aim of producing an integrated device
for isolation of malaria-infected cells from blood samples.
The additional demonstration that leucocytes, and even
sub-populations of leucocytes (T-lymphocytes and neutro-
phils), can be separated both from RBCs as well as from each
other, based on a combination of both size and deformability,
opens potentially new avenues for the use of DLD devices. So
far, whole blood fractionation requires tedious handling invol-
ving density-gradient centrifugation and manual pipetting; or
magnetic separation with appropriate antibodies. Using DLD,
the continuous label-free sorting of blood cells becomes
possible,reducingpreparationtime,costandeffort,whileleav-
ing the cells in their native state. With technological advances
such as described in this paper, the promise of cell mechanics
for characterization and sorting of cell populations is
finally moving towards widespread application in biology,
biotechnology and medicine.
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